FDA approves VIASYS' high frequency ventilator:
This article was originally published in Clinica
The US FDA has approved VIASYS Healthcare's high frequency oscillatory ventilator for treating acute respiratory failure in adults and large children. The SensorMedics 3100B device uses higher distending pressures than conventional ventilators to open the diseased lung units and improve the delivery of oxygen, says the Conshohocken, Pennsylvania firm. It then uses very rapid, small breaths to remove carbon dioxide, thereby reducing injury to the lungs. A paediatric version of the device was launched in 1991.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.